Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.

Morikawa T, Kuchiba A, Lochhead P, Nishihara R, Yamauchi M, Imamura Y, Liao X, Qian ZR, Ng K, Chan AT, Meyerhardt JA, Giovannucci E, Fuchs CS, Ogino S.

Cancer Res. 2013 Mar 1;73(5):1600-10. doi: 10.1158/0008-5472.CAN-12-2276. Epub 2013 Feb 26.

2.

Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.

Morikawa T, Kuchiba A, Yamauchi M, Meyerhardt JA, Shima K, Nosho K, Chan AT, Giovannucci E, Fuchs CS, Ogino S.

JAMA. 2011 Apr 27;305(16):1685-94. doi: 10.1001/jama.2011.513.

3.

Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.

Yamauchi M, Lochhead P, Imamura Y, Kuchiba A, Liao X, Qian ZR, Nishihara R, Morikawa T, Shima K, Wu K, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT, Ogino S.

Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1142-52. doi: 10.1158/1055-9965.EPI-13-0108. Epub 2013 Apr 29.

4.

Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate.

Hanyuda A, Ogino S, Qian ZR, Nishihara R, Song M, Mima K, Inamura K, Masugi Y, Wu K, Meyerhardt JA, Chan AT, Fuchs CS, Giovannucci EL, Cao Y.

Int J Cancer. 2016 Aug 15;139(4):854-68. doi: 10.1002/ijc.30122. Epub 2016 May 10.

PMID:
27037951
5.

A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification.

Nishihara R, Morikawa T, Kuchiba A, Lochhead P, Yamauchi M, Liao X, Imamura Y, Nosho K, Shima K, Kawachi I, Qian ZR, Fuchs CS, Chan AT, Giovannucci E, Ogino S.

Am J Epidemiol. 2013 Jul 1;178(1):84-100. doi: 10.1093/aje/kws431. Epub 2013 Jun 20.

6.

Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study.

Kuchiba A, Morikawa T, Yamauchi M, Imamura Y, Liao X, Chan AT, Meyerhardt JA, Giovannucci E, Fuchs CS, Ogino S.

J Natl Cancer Inst. 2012 Mar 7;104(5):415-20. doi: 10.1093/jnci/djr542. Epub 2012 Feb 6.

7.

Early life body fatness and risk of colorectal cancer in u.s. Women and men-results from two large cohort studies.

Zhang X, Wu K, Giovannucci EL, Ma J, Colditz GA, Fuchs CS, Willett WC, Stampfer MJ, Nimptsch K, Ogino S, Wei EK.

Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):690-7. doi: 10.1158/1055-9965.EPI-14-0909-T. Epub 2015 Mar 16.

8.

Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations.

Nan H, Morikawa T, Suuriniemi M, Imamura Y, Werner L, Kuchiba A, Yamauchi M, Hunter DJ, Kraft P, Giovannucci EL, Fuchs CS, Ogino S, Freedman ML, Chan AT.

J Natl Cancer Inst. 2013 Dec 18;105(24):1852-61. doi: 10.1093/jnci/djt331. Epub 2013 Dec 7.

9.

CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.

Firestein R, Shima K, Nosho K, Irahara N, Baba Y, Bojarski E, Giovannucci EL, Hahn WC, Fuchs CS, Ogino S.

Int J Cancer. 2010 Jun 15;126(12):2863-73. doi: 10.1002/ijc.24908.

10.

Tumor TP53 expression status, body mass index and prognosis in colorectal cancer.

Morikawa T, Kuchiba A, Liao X, Imamura Y, Yamauchi M, Qian ZR, Nishihara R, Sato K, Meyerhardt JA, Fuchs CS, Ogino S.

Int J Cancer. 2012 Sep 1;131(5):1169-78. doi: 10.1002/ijc.26495. Epub 2011 Nov 19.

11.

Comparison of associations of body mass index, abdominal adiposity, and risk of colorectal cancer in a large prospective cohort study.

Keimling M, Renehan AG, Behrens G, Fischer B, Hollenbeck AR, Cross AJ, Leitzmann MF.

Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1383-94. doi: 10.1158/1055-9965.EPI-13-0353. Epub 2013 May 29.

12.

[Body mass index and cancer incidence:a prospective cohort study in northern China].

Guo L, Li N, Wang G, Su K, Li F, Yang L, Ren J, Chang S, Chen S, Wu S, He J, Dai M.

Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Mar;35(3):231-6. Chinese.

PMID:
24831616
13.

Recreational physical activity, body mass index, and survival in women with colorectal cancer.

Kuiper JG, Phipps AI, Neuhouser ML, Chlebowski RT, Thomson CA, Irwin ML, Lane DS, Wactawski-Wende J, Hou L, Jackson RD, Kampman E, Newcomb PA.

Cancer Causes Control. 2012 Dec;23(12):1939-48. doi: 10.1007/s10552-012-0071-2. Epub 2012 Oct 2.

14.

Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition.

Norat T, Bingham S, Ferrari P, Slimani N, Jenab M, Mazuir M, Overvad K, Olsen A, Tjønneland A, Clavel F, Boutron-Ruault MC, Kesse E, Boeing H, Bergmann MM, Nieters A, Linseisen J, Trichopoulou A, Trichopoulos D, Tountas Y, Berrino F, Palli D, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Engeset D, Lund E, Skeie G, Ardanaz E, González C, Navarro C, Quirós JR, Sanchez MJ, Berglund G, Mattisson I, Hallmans G, Palmqvist R, Day NE, Khaw KT, Key TJ, San Joaquin M, Hémon B, Saracci R, Kaaks R, Riboli E.

J Natl Cancer Inst. 2005 Jun 15;97(12):906-16.

15.

Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.

Lachenmayer A, Alsinet C, Savic R, Cabellos L, Toffanin S, Hoshida Y, Villanueva A, Minguez B, Newell P, Tsai HW, Barretina J, Thung S, Ward SC, Bruix J, Mazzaferro V, Schwartz M, Friedman SL, Llovet JM.

Clin Cancer Res. 2012 Sep 15;18(18):4997-5007. Epub 2012 Jul 18.

16.

A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.

Ogino S, Nosho K, Baba Y, Kure S, Shima K, Irahara N, Toyoda S, Chen L, Kirkner GJ, Wolpin BM, Chan AT, Giovannucci EL, Fuchs CS.

Am J Gastroenterol. 2009 Aug;104(8):2047-56. doi: 10.1038/ajg.2009.281. Epub 2009 Jun 9.

17.

Physical activity, obesity, and risk of colorectal adenoma in women (United States).

Giovannucci E, Colditz GA, Stampfer MJ, Willett WC.

Cancer Causes Control. 1996 Mar;7(2):253-63.

PMID:
8740738
18.

Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies.

Gibson TM, Park Y, Robien K, Shiels MS, Black A, Sampson JN, Purdue MP, Freeman LE, Andreotti G, Weinstein SJ, Albanes D, Fraumeni JF Jr, Curtis RE, Berrington de Gonzalez A, Morton LM.

J Clin Oncol. 2014 Dec 10;32(35):4004-11. doi: 10.1200/JCO.2014.56.8444. Epub 2014 Sep 29.

19.

Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women.

Zhang X, Giovannucci EL, Wu K, Gao X, Hu F, Ogino S, Schernhammer ES, Fuchs CS, Redline S, Willett WC, Ma J.

Sleep. 2013 May 1;36(5):681-8. doi: 10.5665/sleep.2626.

20.

Aspirin use and risk of colorectal cancer according to BRAF mutation status.

Nishihara R, Lochhead P, Kuchiba A, Jung S, Yamauchi M, Liao X, Imamura Y, Qian ZR, Morikawa T, Wang M, Spiegelman D, Cho E, Giovannucci E, Fuchs CS, Chan AT, Ogino S.

JAMA. 2013 Jun 26;309(24):2563-71. doi: 10.1001/jama.2013.6599.

Supplemental Content

Support Center